← Latest news 
India drug regulator slashes approval timelines by over 50% and eases key rules
Economy
Published on 24 April 2026
Clinical trials now approved in roughly four months
India’s drug regulator has accelerated pharma innovation by cutting approval timelines by more than half. Clinical trial approvals will now take about 120-135 days, while marketing authorisations are cleared in under 150 days. The reforms also remove certain pre-clinical approval requirements, aiming to strengthen ease of doing business and speed product delivery.
- Approval timelines cut by over 50% for clinical trials and marketing
- Clinical trial clearances now take about 120 to 135 days
- Marketing authorisations are issued in under 150 days
- Pre-clinical approval requirements have been eased
Read the full story at The Economic Times
This summarization was done by Beige for a story published on 
The Economic Times